Daniel M. Ratner

University Of Washington

$678,895

Attributed

$2,715,581

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $633.1K · FY2018–22

$1M$750K$500K$250K$0

'18

'19

'20

'21

'22

Funding mix

By agency

NIH$2,715,581 · 1

By mechanism

R01$2,715,581 · 1

Top collaborators

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Aerosols”

Kevin William Riley · University Of California Los Angeles$11,403,756
Bryce Beverlin II · Quench Medical, Inc.$5,631,185
Lu Hu · University Of Montana$4,297,456
Barney Sparrow · Battelle Memorial Institu$4,131,523
Matthew Reed · Nob Hill Therapeutics, Inc.$4,021,634
Joanna E Cohen · Virginia Commonwealth University$4,004,135

Research focus

AerosolsAlveolarAlveolar MacrophagesAminoglycoside AntibioticsAnalytical MethodAntibioticsAntibiotic TherapyAnti-Infective AgentsAntimicrobialArchitectureAreaBacteriaBacterial InfectionsBactericideBaseBeta-LactamsBiodistributionBiological AvailabilityBiomaterial CompatibilityBiosafety Level 3 FacilityBiothreatBloodBurkholderia PseudomalleiAerosolized

Grant awards (5)

Engineered Antimicrobial Platform to Target Pulmonary Intracellular Infections$633,062

R01 · FY2022 · AI

Engineered Antimicrobial Platform to Target Pulmonary Intracellular Infections$583,781

R01 · FY2021 · AI

Engineered Antimicrobial Platform to Target Pulmonary Intracellular Infections$512,525

R01 · FY2020 · AI

Engineered Antimicrobial Platform to Target Pulmonary Intracellular Infections$493,087

R01 · FY2019 · AI

Engineered Antimicrobial Platform to Target Pulmonary Intracellular Infections$493,126

R01 · FY2018 · AI